lentiviral packaging vectors pmd2 g (Addgene inc)
Addgene inc is a verified supplier 
98
Structured Review
Addgene inc
lentiviral packaging vectors pmd2 g
Lentiviral Packaging Vectors Pmd2 G, supplied by Addgene inc, used in various techniques. Bioz Stars score: 98/100, based on 14751 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/lentiviral+packaging+vectors/pMD2%2EG+(Plasmid+%2312259)/pm41891922-347-22-28
Average 98 stars, based on 14751 article reviews
Lentiviral Packaging Vectors Pmd2 G, supplied by Addgene inc, used in various techniques. Bioz Stars score: 98/100, based on 14751 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/lentiviral+packaging+vectors/pMD2%2EG+(Plasmid+%2312259)/pm41891922-347-22-28
Average 98 stars, based on 14751 article reviews
lentiviral packaging vectors pmd2 g - by Bioz Stars,
2026-09
98/100 stars
Images
Related Articles
Plasmid Preparation:Article Title: Development of CRISPR/Cas13-based analytical tools to study RNA-Protein Interactions Article Snippet: 3xHA-TurboID-NLS_pCDNA3 was a gift from Alice Ting (Addgene plasmid # 107171; http://n2t.net/addgene:107171 ; RRID:Addgene_107171). lentiCas9-Blast (Addgene plasmid # 52962; http://n2t.net/addgene:52962 ; RRID:Addgene_52962) and lentiGuide-Puro (Addgene plasmid # 52963; http://n2t.net/addgene:52963 ; RRID:Addgene_52963) were gifts from Feng Zhang. .. Article Title: Supporting Information for CITED2 is a Conserved Regulator of the Uterine-Placental Interface Article Snippet: A control shRNA that does not target any known mammalian gene, pLKO.1-shSCR (plasmid 1864), was obtained from Addgene. .. Article Title: NOTUM-mediated WNT silencing drives extravillous trophoblast cell lineage development. Article Snippet: .. Article Title: YTHDF2 promotes ATP synthesis and immune evasion in B cell malignancies. Article Snippet: In brief YTHDF2 modulates oncogenic transformation and immune evasion across multiple B cell cancers by stabilizing mC-modified mRNAs and destabilizing mA-modified mRNAs, thereby serving as a dual reader for both mC and mA modifications.. Small molecules that target YTHDF2 reduce ATP synthesis and are therapeutic candidates for B cell malignancies, especially when combined with CAR-T therapy or bispecific engagers. Article Title: Effects Of Aryl Hydrocarbon Receptor Ligand TCDD On Human Trophoblast Cell Development Article Snippet: .. Construct:Article Title: Profiling of HeLa nucleoplasmic and nucleolar RNAs by Halo-seq proximity labeling Article Snippet: .. The transfer vectors carrying the Halo-fusion constructs (HaloTag-EGFP-NLS and Halo-EGFP-Fibrillarin) were co-transfected with Transfection:Article Title: HAND1 level controls the specification of multipotent cardiac and extraembryonic progenitors from human pluripotent stem cells Article Snippet: The entry vector was recombined with the destination vector FU-tetO-Gateway (Addgene #43914) using GatewayTM LR ClonaseTM II Enzyme Mix (ThermoFisher ScientificTM) and transformed into One ShotTM Stbl3TM Chemically Competent cells (ThermoFisher ScientificTM). .. The Article Title: The level of HAND1 controls the specification of multipotent cardiac and extraembryonic progenitors Article Snippet: The entry vector was recombined with the destination vector FU-tetO-Gateway (Addgene #43914) using GatewayTM LR ClonaseTM II Enzyme Mix (Thermo Fisher Scientific) and transformed into One ShotTM Stbl3TM Chemically Competent cells (Thermo Fisher Scientific). .. The Retroviral:Article Title: YTHDF2 promotes ATP synthesis and immune evasion in B cell malignancies. Article Snippet: In brief YTHDF2 modulates oncogenic transformation and immune evasion across multiple B cell cancers by stabilizing mC-modified mRNAs and destabilizing mA-modified mRNAs, thereby serving as a dual reader for both mC and mA modifications.. Small molecules that target YTHDF2 reduce ATP synthesis and are therapeutic candidates for B cell malignancies, especially when combined with CAR-T therapy or bispecific engagers. |